ALL NEWS
NEWS:
- 2024-09: Recent guideline from the British Society of Haematology on the measurement of direct oral anti-coagulants lists the DOASENSE point-of-care test [read here]
- 2024-07: New series of interviews with users of the DOASENSE test launched. Find out more about their experiences and use cases. [watch videos]
- 2024-04: DOASENSE test included in new Guideline published by the European Society of Anaesthesiology and Intensive Care [read more]
- 2024-02: Expert consensus published on algorithm for rapid exclusion of clinically relevant plasma levels of DOACs using the DOAC Dipstick [download here]
- 2024-01: Updated version of White Paper available with a summary of key publications on the DOASENSE test suite [download here]
- 2023-11: DOASENSE becoming a standard of care in Italy and Estonia [read more]
- 2023-09: DOASENSE announces new partnership with PHILCARE as appointed exclusive distributor for the Philippines [contact details]
- 2023-05: New partnership with Eurobio Scientific -- appointed exclusive distributor of DOASENSE solutions in France [read more / contact details]
- 2023-02: New study published in STROKE, provides evidence for using the DOAC Dipstick test to identify patients for prompt thrombolysis [read more]
- 2022-12: In-person meetings are back! Meet the DOASENSE team and products at these 2023 congresses: [read more]
- 2022-07: New study published on the use of the DOASENSE point-of-care test to detect DOAC exposure at a large Emergency Department [read more]
- 2022-05: Editoral emphasizes the relevance of the DOAC Dipstick test [read more]
- 2022-03: Latest data on the DOASENSE DOAC point-of-care test presented at GTH 2022, honored with Best Poster award [review congress presentations]
- 2022-02: DOAC Dipstick testing can reliably exclude the presence of clinically relevant DOAC concentrations in plasma [download open access paper]
- 2022-01: DOASENSE announces new partnership with Mediq as appointed exclusive distributor for Estonia [read more]
- 2021-12: Value of DOASENSE's rapid POC test for DOACs mentioned in Australasian Anaesthesia Blue Book [download the Blue Book and refer to pages 160 & 163]
- 2021-09: First meta-analysis published on DOAC Dipstick for detection of Direct Oral Anticoagulants in patient urine samples [download open access paper]
- 2021-07: Growing number of studies confirm clinical value of the DOASENSE DOAC test [review congress presentations]
- 2021-05: DOASENSE rapid test suite for direct oral anticoagulants receives ANVISA approval in Brazil [read more]
- 2021-04: ANTICOAGULATION FORUM’s latest guidance on the “Reversal and Treatment Strategies for DOAC-Related Bleeding” includes our DOASENSE point-of-care test [read more]
- 2021-04: Watch the recording of a great webinar on "DOAC Testing in Critical Care", organized by our partner Haemoview Diagnostics [watch the webinar here]
- 2021-03:Interview with German trauma surgeon emphasizes the importance of rapid point-of-care testing on DOACs in cases of fractures near the hip joint [read in German or the English convenience translation]
- 2021-02: New scientific and clinical analyses of DOASENSE's DOAC urine test to be presented at GTH 2021 Virtual Congress [read more]
- 2021-02: UK’s National Institute for Health and Care Excellence (NICE) provided guidance on our DOAC Dipstick point-of-care test for detecting direct oral anticoagulants [read more]
- 2021-02: Germany’s Federal Joint Committee (Gemeinsamer Bundesausschuss G-BA ) decided to expand guideline for care of hip fracture to include regulations on testing for DOACs, mentions DOAC Dipstick as suitable test [read more]
- 2021-01: DOASENSE expands availability of its products to Portugal and Spain, partners with BIOMETA [read more]
- 2020-12: Our new Online Training & Certification website is now available [go to Online Training]
- 2020-11: DOASENSE announces new partnership with SUNMEDCARE as appointed exclusive distributor for Brazil [read more]
- 2020-09: We are delighted to announce the appointment of A De Mori as exclusive distributors of DOASENSE solutions in Italy [read more]
- 2020-06: Our product suite is now registered with the Australian TGA and locally available through Haemoview Diagnostics [visit Haemoview]
- 2020-05: KBM Pharm joins the ranks of exclusive distributors of the DOAC Dipstick IVD test, addressing the markets in South Korea [contact details]
- 2020-04: MEDISTA has been appointed as exclusive distributor of the DOASENSE product suite for the Czech Republic [go to list of Distributors]
- 2020-02: Industry Expert Remi Corlin joins DOASENSE as International Markets Consultant [read more]
- 2020-01: DOASENSE will present its suite of point-of-care DOAC tests at these upcoming conferences:
- ANIM, Karlsruhe (Germany) - 30 Jan - 1 Feb (booth # 27)
- GTH, Bremen (Germany) - 18 - 21 Feb (booth # 65)
- 2019-12: "Thrombosis and Haemostasis" editorial emphasizes the innovation of DOASENSE's DOAC Dipstick point-of-care test [read editorial], and publication on multicenter study favorably reviewed by NATA [read NATA review]
- 2019-11: New publication on postmarketing multicenter study confirms strong performance of DOAC Dipstick point-of-care test for direct oral anticoagulants [article]
- 2019-10: DOAC Dipstick featured in "Game Changer" section of new update on laboratory assessment for direct oral anticoagulants [article]
- 2019-10: DOASENSE has appointed Haemoview Diagnostics (HVD) as exclusive distributor of its DOAC point-of-care test suite for Australia and New Zealand [Contact HVD]
- 2019-09: DOASENSE exhibits at these upcoming fall 2019 conferences:
- FELS, Freiburg (Germany) - 8 NOV
- DGN, Stuttgart (Germany) - 25 -27 SEPT
- HAI, Berlin (Germany) - 19 - 20 SEPT
- 2019-07: DOASENSE Announces Commercial Launch of the First Complete Suite of Products for Rapid Point-of-Care DOAC Testing [Read more]
- 2019-01: Meet us at these upcoming 2019 conferences:
- Laborforum, Hannover (Germany) - 30 JAN - together with the HITADO-SYSMEX team
- GTH, Berlin (Germany) - 27 FEB - 2 MAR - DOASENSE booth & lunch symposium [PROGRAMME]
- POCT Symposium, Munich (Germany) - 11-13 MAR - together with the HITADO-SYSMEX team (SYSMEX booth)
- DAC, Leipzig (Germany) - 9-11 MAY - together with the HITADO-SYSMEX team (SYSMEX booth)
- Laborforum, Dortmund (Germany) - 26 JUNE - together with the HITADO-SYSMEX team
- ISTH, Melbourne (Australia) - 6-10 JULY - DOASENSE booth
- 2018-11: The DOAC Dipstick point-of-care test is now commercially available in Germany through HITADO [ORDER HERE] / Der DOAC Dipstick Point-of-Care-Test ist nun in Deutschland über HITADO erhältlich [BESTELLEN SIE HIER]
- 2018-09: First peer-reviewed paper on our DOAC Dipstick point-of-care test has recently been published in Seminars in Thrombosis & Hemostasis
[Free open access download of the epub ahead of print HERE]
- 2018-08: Meet us in Munich during the ESC 2018 at booth # G620. And please also visit the websites of Thrombosis UK, which recently featured latest data on our DOAC Dipstick test [Link]
- 2018-07: We are getting ready for ISTH-SSC. Please visit us in Dublin at booth # H2.
- 2018-05: The International Council for Standardization in Haematology (ICSH) has included DOASENSE's DOAC Dipstick test in its 2018 Recommendations for Laboratory Measurement of Direct Oral Anticoagulants [ICSH Guidelines]
- 2018-04: We have started the controlled launch of our DOAC Dipstick test with select clinics in Germany.
- 2018-03: Join us at these upcoming conferences and trade shows, where DOASENSE will be present with a booth:
- DGK 2018, Mannheim (Germany) - April 4-7 - Annual Meeting of the German Cardiac Society
- ISTH-SSC 2018, Dublin (Ireland) - July 18-21 - SSC Meeting of the International Society of Thrombosis and Haemostasis
- ESC 2018, Munich (Germany) - August 25-29 - Congress of the European Society of Cardiology
- 2018-02: DOASENSE's exhibit at the 62nd Annual Meeting of the Society of Thrombosis and Hemostasis Research (GTH 2018) in Vienna received broad interest from the attending community
- 2018-01: Our patented DOAC Dipstick product was CE marked according to European Directive 98/79/EC (IVDD)
- 2017-12: The Quality Management System of DOASENSE GmbH has been certified by LRQA in accordance with ISO 13485:2016 [Certificate of Approval]
- 2017-08: DOASENSE press release on presentation of first-ever Point-of-Care urine test for Direct Oral Anticoagulants (DOACs) [Read more]
- 2017-07: DOASENSE is proud BRONZE SPONSOR of the ISTH 2017 in Berlin
NOTE: DOASENSE(TM) products may not be available or approved in your country.